Healium at ICI2025

This week at the ICI 2024 conference, we had the privilege of showcasing our flagship innovation—Echomplish™ Dual-Mode Ultrasound Technology—on stage. Representing Healium Medical was our esteemed collaborator, Prof. Saar Mincha, who delivered a powerful presentation on how Echomplish is redefining the future of ablation therapy.

Echomplish is more than a device—it’s a platform built to personalize treatment, automatically titrate power, and monitor therapy in real time. Our stand-alone system integrates advanced ultrasound imaging and ablation into a single, intuitive console, enabling non-contact, continuous lesion creation with unmatched precision and safety.

Prof. Mincha’s insights into the clinical potential of Echomplish—especially in treating hypertension and other cardiovascular conditions—sparked meaningful conversations with physicians, researchers, and industry leaders from around the world.

We’re proud to be part of the innovation ecosystem that ICI fosters and even prouder to see Echomplish gaining recognition as a transformative solution in interventional cardiology.

Onward and upward!